Diazyme Laboratories, Inc.

Diazyme Laboratories, Inc. Diazyme is a clinical chemistry reagent manufacturer that develops IVD assays for use on conventional open channel automated chemistry platforms.

What Sets Diazyme Laboratories Apart? At Diazyme Laboratories, we pride ourselves on offering diagnostic solutions that ...
01/27/2026

What Sets Diazyme Laboratories Apart?

At Diazyme Laboratories, we pride ourselves on offering diagnostic solutions that lead the industry in innovation and reliability. Here’s what makes us stand out:

🔬 Innovative Technology: Our assays are designed with cutting-edge technology to deliver precise and dependable results. Our solutions support early detection and effective management across various medical conditions.

💡 Comprehensive Assay Menu: We provide an extensive range of FDA-cleared assays, covering a wide array of diagnostic needs. This breadth ensures our clients have access to comprehensive diagnostic tools for diverse applications.

📈 High-Performance Efficiency: With products like the DZ-Lite™ c270 analyzer, we offer rapid and accurate results with high throughput. Our solutions enhance efficiency, enabling healthcare professionals to make timely and informed decisions.

🛠️ User-Friendly Design: Our instruments are crafted for ease of use and seamless integration. From intuitive interfaces to compact designs, we prioritize user experience to fit diverse clinical environments.

🌍 Commitment to Quality: Quality and reliability are at the core of our mission. We are committed to continuous improvement, ensuring that our diagnostic tools meet the highest standards of excellence.

Discover how Diazyme Laboratories can enhance your diagnostic capabilities and support better patient outcomes: https://bit.ly/36lKaaV

Comprehensive Cardiovascular Insights with Diazyme’s Advanced Biomarkers ❤️🔬Cardiovascular disease remains a leading hea...
01/22/2026

Comprehensive Cardiovascular Insights with Diazyme’s Advanced Biomarkers ❤️🔬

Cardiovascular disease remains a leading health challenge, but early detection through reliable biomarkers can change outcomes. At Diazyme Laboratories, we offer a comprehensive suite of cardiovascular markers to support early risk assessment, diagnosis, and proactive care.

Our innovative assays help clinicians assess critical risk factors by monitoring the following biomarkers:

🩺 Key Cardiovascular Markers:

• PLAC (Phospholipase A2): A key indicator linked to inflammation and cardiovascular disease risk.
• OxPL (Oxidized Phospholipids): Markers of oxidative stress and atherosclerosis progression.
• OxLDL (Oxidized LDL): A critical biomarker for atherosclerosis and cardiovascular risk.
• Homocysteine: Elevated levels associated with endothelial dysfunction and cardiovascular disease.
• HDL3 (High-Density Lipoprotein Subfraction): A protective lipoprotein that supports cardiovascular health.
• ApoB (Apolipoprotein B): A marker for LDL particles and cardiovascular risk assessment.
• HDL & LDL: Assessments of cholesterol levels to determine cardiovascular risk.
• Lp(a) (Lipoprotein(a)): A genetic risk marker linked to cardiovascular disease.
💡 Why These Markers Matter:
These biomarkers provide a window into inflammation, cholesterol health, endothelial dysfunction, and other pathways critical to cardiovascular health. Early detection allows for timely, evidence-based strategies to reduce risk and improve outcomes.

Take control of cardiovascular health with Diazyme’s trusted diagnostic solutions.

👉 Learn how our testing can support your clinical goals and help improve patient care.: https://bit.ly/3MlnU6y

(a)

Heading to WHX Labs 2026? Let’s connect.We’re excited to be exhibiting at this year’s World Health Expo Labs and showcas...
01/21/2026

Heading to WHX Labs 2026? Let’s connect.

We’re excited to be exhibiting at this year’s World Health Expo Labs and showcasing our latest innovations in clinical diagnostics, including new research-use panels, high-sensitivity assays, and laboratory automation platform.

If you’re attending, now is the perfect time to schedule a meeting with our team. Whether you're interested in expanding your assay menu, exploring new research tools, or discussing partnership opportunities, we’d love to talk.

📅 Secure your meeting slot in advance to get a personalized look at what’s new and what’s coming next: https://bit.ly/4jtxWT3

Now Hiring! Join Diazyme – Innovating Diagnostics for a Healthier World!We are seeking a dynamic Regional Sales Represen...
01/20/2026

Now Hiring!

Join Diazyme – Innovating Diagnostics for a Healthier World!

We are seeking a dynamic Regional Sales Representative – Diagnostic Medical Devices to drive business growth and build strong customer relationships across the South-Central Region (TX, CO, OK, KS, NE, MO, AR).

What You’ll Do:
- Develops market/product line business plans and capture plans to support sales in designated market segments.
- Advises management on status or action required in connection with existing and potential sales programs.
- Assists in supplying business development input and administrative control for specific projects within the group.
- Analyze market trends to uncover new opportunities.

Make a difference in healthcare today!

Apply now: https://bit.ly/4pwXDnd

Elevating Lipid Diagnostics with Diazyme's Lp(a) AssayAt Diazyme Laboratories, we’re committed to supporting the advance...
01/15/2026

Elevating Lipid Diagnostics with Diazyme's Lp(a) Assay

At Diazyme Laboratories, we’re committed to supporting the advancement of cardiovascular diagnostics with solutions that deliver accuracy, reliability, and clinical relevance. Our Lipoprotein (a) [Lp(a)] Assay is designed to provide dependable results that are essential for evaluating independent cardiovascular risk, particularly in individuals with a family history of premature heart disease.

Key advantages of Diazyme’s Lp(a) Assay:
• Reports in both mg/dL and nmol/L to align with current clinical recommendations
• Fully automated and compatible with most chemistry analyzers
• Traceable to the WHO/IFCC reference material SRM 2B
• Wide measuring range and excellent precision
• Minimal interference from triglycerides, bilirubin, hemoglobin, and ascorbic acid

As lipid testing standards continue to evolve, Diazyme remains focused on equipping laboratories with solutions that enhance clinical decision-making and support proactive cardiovascular care.

Learn more: https://bit.ly/4l6Anea

Diazyme Laboratories, Inc. announces 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the evaluatio...
01/14/2026

Diazyme Laboratories, Inc. announces 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the evaluation of monoclonal gammopathy of undetermined significance (MGUS) using Diazyme’s Kappa and Lambda Free Light Chain Assays.

👉 Read the full press release: https://bit.ly/4pFf3Or

Why Monitor Kappa & Lambda Free Light Chains?Normally, there's a balance between kappa and lambda free light chains in t...
01/14/2026

Why Monitor Kappa & Lambda Free Light Chains?

Normally, there's a balance between kappa and lambda free light chains in the bloodstream. However, in certain diseases, particularly plasma cell disorders such as multiple myeloma, there can be an imbalance in the production of these free light chains. This imbalance can lead to an excess of one type of light chain over the other, which is known as a kappa-lambda ratio imbalance.

This imbalance can be detected through laboratory tests, such as Diazyme’s Kappa and Lambda serum free light chain assays, which measures the levels of kappa and lambda free light chains in the blood. Monitoring the kappa-lambda ratio is important in the diagnosis and management of plasma cell disorders.

Learn More about these assays and to support healthcare providers in assessing disease progression and response to treatment.
https://bit.ly/4h7z6kn

We’re excited to announce that Diazyme will be attending the World Health Expo Labs this year! 🎉Join us at block H3.G16 ...
01/12/2026

We’re excited to announce that Diazyme will be attending the World Health Expo Labs this year! 🎉

Join us at block H3.G16 to explore our latest innovations in diagnostics and see how our cutting-edge assays and instruments are making a difference in patient care. Our team will be on hand to showcase our products, discuss the future of diagnostics, and answer any questions you may have.

We can’t wait to connect with industry experts, healthcare professionals, and innovators who are shaping the future of diagnostics. Don’t miss the chance to learn more about what makes Diazyme a leader in the field.

See you at WHX Labs! 👋

Register to attend today: https://bit.ly/4blZI1I

Welcome Back!With a new year comes new excitement for innovations and accomplishments.What are you looking forward to in...
01/07/2026

Welcome Back!

With a new year comes new excitement for innovations and accomplishments.

What are you looking forward to in the Clinical Chemistry space for 2026?

https://bit.ly/36lKaaV

🎉 Cheers to 2026! 🎉As we step into the New Year, Diazyme Laboratories is excited about the incredible innovations and bi...
12/31/2025

🎉 Cheers to 2026! 🎉

As we step into the New Year, Diazyme Laboratories is excited about the incredible innovations and big plans we have in store for 2026! This year, we are committed to advancing healthcare through cutting-edge diagnostic solutions, expanding our product offerings, and strengthening our partnerships with labs and healthcare professionals worldwide.

We can’t wait to unveil new technologies and advancements that will enhance lab efficiency, improve patient outcomes, and help shape the future of diagnostics. With a focus on automation, precision, and accessibility, we’re ready to make an even bigger impact in the diagnostic space this year!

Stay tuned—2026 will be a year of growth, progress, and innovation at Diazyme.

✨ Here’s to a successful year ahead! ✨

Happy Holidays from Diazyme Laboratories! As the year comes to a close, we want to take a moment to express our gratitud...
12/24/2025

Happy Holidays from Diazyme Laboratories!

As the year comes to a close, we want to take a moment to express our gratitude for all of our customers and partners who have made this year a success. We are thankful for your continued trust and collaboration, and we look forward to even more exciting opportunities in the year ahead!

A heartfelt thank you to each member of our team for your passion, resilience, and impact in advancing diagnostic solutions. You are truly the driving force behind our success!

Wishing you all a joyful and restful holiday season, filled with peace, happiness, and good health. Here's to a bright and prosperous New Year!

Discover the Impact of Diazyme’s Diagnostic Solutions 🔬At Diazyme Laboratories, we’re honored to work with forward-think...
12/10/2025

Discover the Impact of Diazyme’s Diagnostic Solutions 🔬

At Diazyme Laboratories, we’re honored to work with forward-thinking professionals like Dr. Alan H.B. Wu, Ph.D., a long-time partner and pioneer in diagnostics. Dr. Wu has integrated Diazyme’s Free Light Chain and ADA assays into his lab to improve diagnostic accuracy for conditions like Multiple Myeloma and Tuberculosis.

In his testimonial, Dr. Wu shares how these assays are filling critical gaps in his lab’s workflows, enabling timely and precise patient care.

👉 Visit our website to read Dr. Wu’s story and watch the full video. Discover how Diazyme can empower your lab to make a difference in patient outcomes. https://bit.ly/4amS1aX

Address

12889 Gregg Court
Poway, CA
92064

Alerts

Be the first to know and let us send you an email when Diazyme Laboratories, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Diazyme Laboratories, Inc.

Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme's products include test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes.

Diazyme Laboratories, an affiliate of General Atomics, is located in Poway, California and is a cGMP and ISO 13485 certified medical device manufacturer.